Immunome, Inc. (IMNM)
NASDAQ: IMNM · Real-Time Price · USD
17.06
-0.13 (-0.73%)
Nov 18, 2026, 1:13 PM EST - Market open
Immunome Employees
Immunome had 267 employees as of September 30, 2026. The number of employees increased by 99 or 58.93% compared to the same quarter last year. That makes Immunome the 24,719th largest employer in the world and 3,165th in the United States.
Employees
267
Change (1Y)
99
Growth (1Y)
58.93%
Revenue / Employee
n/a
Profits / Employee
-$1,058,610
Market Cap
2.01B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Sep 30, 2026 | 267 | 99 | 58.93% |
| Jun 30, 2026 | 247 | 92 | 59.35% |
| Mar 31, 2026 | 206 | 75 | 57.25% |
| Dec 31, 2025 | 177 | 59 | 50.00% |
| Sep 30, 2025 | 168 | 63 | 60.00% |
| Jun 30, 2025 | 155 | 77 | 98.72% |
| Mar 31, 2025 | 131 | 69 | 111.29% |
| Dec 31, 2024 | 118 | 63 | 114.55% |
| Sep 30, 2024 | 105 | 50 | 90.91% |
| Jun 30, 2024 | 78 | - | - |
| Mar 31, 2024 | 62 | 25 | 67.57% |
| Dec 31, 2023 | 55 | 18 | 48.65% |
| Dec 31, 2022 | 37 | -2 | -5.13% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Fortrea Holdings | 14,000 |
| Beam Therapeutics | 557 |
| Maravai LifeSciences Holdings | 410 |
| Vera Therapeutics | 362 |
| Harmony Biosciences Holdings | 293 |
| Biohaven | 274 |
| Zenas BioPharma | 167 |
| Septerna | 134 |
IMNM News
- 5 hours ago - Immunome to Present at Upcoming Investor Conferences - Business Wire
- 8 days ago - Immunome registers to sell 4.43M shares of common stock for holders - TheFly
- 8 days ago - Immunome files automatic mixed securities shelf - TheFly
- 8 days ago - Immunome price target lowered to $30 from $33 at Piper Sandler - TheFly
- 8 days ago - Immunome price target lowered to $23 from $24 at Stifel - TheFly
- 8 days ago - Immunome Transcript: 3rd Annual Guggenheim Healthcare Innovation Conference - Transcripts
- 8 days ago - Immunome reports Q3 EPS (76c), consensus (60c) - TheFly
- 8 days ago - Immunome Reports Third Quarter 2026 Financial Results and Provides Business Update - Business Wire